Iron oxide nanoparticles for targeted cancer imaging and diagnostics
- PMID: 21930108
- DOI: 10.1016/j.nano.2011.08.017
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) have proven to be highly effective contrast agents for the magnetic resonance imaging diagnosis of solid tumors. This review examines the various techniques that are available to selectively target SPIONs toward a wide variety of cancerous tissues, with specific attention given to how the surface properties imparted by various targeting ligands affect the particles tissue distribution and pharmacokinetics. An in-depth examination of the various human cell lines utilized to test the assorted targeting methods is also presented, as well as an overview of the various types of cancer against which each targeting method has been utilized for both in vivo and in vitro studies. From the Clinical Editor: Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) are very potent negative contrast materials for magnetic resonance imaging-based diagnosis. This comprehensive review examines techniques that selectively target SPIONs toward a wide variety of malignancies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.J Control Release. 2012 Oct 28;163(2):111-8. doi: 10.1016/j.jconrel.2012.08.029. Epub 2012 Sep 3. J Control Release. 2012. PMID: 22964395
-
Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.Langmuir. 2009 Feb 17;25(4):2060-7. doi: 10.1021/la8036499. Langmuir. 2009. PMID: 19166276
-
Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.J Nucl Med. 2013 Nov;54(11):1974-80. doi: 10.2967/jnumed.113.122267. Epub 2013 Sep 19. J Nucl Med. 2013. PMID: 24050935
-
Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.J Control Release. 2013 Jul 10;169(1-2):48-61. doi: 10.1016/j.jconrel.2013.03.018. Epub 2013 Apr 6. J Control Release. 2013. PMID: 23567046 Review.
-
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.Nanomedicine. 2016 Feb;12(2):287-307. doi: 10.1016/j.nano.2015.10.019. Epub 2015 Dec 18. Nanomedicine. 2016. PMID: 26707817 Review.
Cited by
-
Selective magnetic resonance imaging of magnetic nanoparticles by acoustically induced rotary saturation.Magn Reson Med. 2016 Jan;75(1):97-106. doi: 10.1002/mrm.25522. Epub 2014 Dec 23. Magn Reson Med. 2016. PMID: 25537578 Free PMC article.
-
Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo.Int J Nanomedicine. 2015 Apr 1;10:2595-617. doi: 10.2147/IJN.S79367. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25878495 Free PMC article.
-
SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects.Nanomaterials (Basel). 2022 Oct 20;12(20):3686. doi: 10.3390/nano12203686. Nanomaterials (Basel). 2022. PMID: 36296877 Free PMC article. Review.
-
Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.Theranostics. 2018 May 11;8(12):3284-3307. doi: 10.7150/thno.25220. eCollection 2018. Theranostics. 2018. PMID: 29930730 Free PMC article. Review.
-
ENO1-targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging.J Cell Mol Med. 2020 May;24(10):5751-5757. doi: 10.1111/jcmm.15237. Epub 2020 Apr 13. J Cell Mol Med. 2020. PMID: 32285549 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources